1. BAILLIE GIFFORD. GLOBAL INVESTMENT MANAGERS.

    AS A PRIVATE PARTNERSHIP WE HAVE NEVER SHOUTED “ABOUT US”. SO LET’S HAVE A QUIET CHAT.

    Baillie Gifford is unique in the UK in being a large-scale investment business that has remained an independent private partnership. This ownership structure has allowed us to keep our efforts focused entirely on our clients and their investments.

  2. Read more
    Press Release
    Baillie Gifford introduces equal parental leave.
    Baillie Gifford has introduced a new parental leave policy which offers up to 52 weeks leave.
    Read more
    Find out more
    Press
    Today’s Pain Could Be Tomorrow’s Gain.
    Richard Sneller joins a Barron’s roundtable on emerging markets.
    Find out more
    Find out more
    Actual investors think in decades.

    Not quarters.
    Find out more
    Download
    Press
    The Authors of Our Success.
    Nick Thomas tells the Daily Telegraph how our literary sponsorship helps us avoid following the herd.
    Download
    Download
    Press
    Benefiting Society as Well as Investors.
    Stuart Dunbar tells the Daily Telegraph what investing is really about.
    Download
    Find out more
    Baillie Gifford Prize for Non-Fiction
    Serhii Plokhy wins 2018 Baillie Gifford Prize for Non-Fiction.
    Serhii Plokhy has won the 2018 Baillie Gifford Prize for Non-Fiction for his compelling book Chernobyl: History of a Tragedy.
    Find out more
    Download
    Press
    The FTSE 100 is Frozen.
    James Anderson speaks to the Daily Telegraph about what’s wrong with the UK stock market.
    Download
    Read more
    About Us
    Our Shared Beliefs.
    We believe that our strong core beliefs are as important to our clients as they are to our staff, but what are they?
    Read more
  3. Actual investors are focused.

    Not frantic.
    Find out more
  4. Read more
    Insights
    The Great Convergence of Medicine.
    The future of medicine is likely to be fundamentally different from what we know today. Investment Manager, Rose Nguyen, discusses the technological advances that are likely to transform life science in the coming decades.
    Read more
    Read more
    Insights
    A Future Powered By Artificial Intelligence.
    With the power to transform every trade and every industry, artificial intelligence (AI) is the future that is here today. Investment manager Lawrence Burns reflects on some of the recent developments in the field and speculates on what the brave and wonderful new world of AI might mean for us all.
    Read more
    Find out more
    Corporate Citizenship
    Focus on Sponsorship.
    We focus our corporate philanthropy efforts on initiatives where Baillie Gifford’s contribution can make a real difference, as our Focus on Sponsorship brochure illustrates.
    Find out more
    Read more
    Insights
    Comparing Neighbours - China vs Japan.
    China may indeed be sitting at the bottom of an opportunity curve, but will its ‘new economy’ deliver, or will China go the same way as its neighbour, Japan? Andrew Keiller explains why China won’t be the next Japan.
    Read more
    Read more
    Insights
    An End to Cancer?
    Investment manager Julia Angeles strikes an optimistic note as she explores some of the recent developments in healthcare, which one day she hopes will bring an end to cancer.
    Read more
    Watch
    Corporate Citizenship
    Shining a light on our world heritage home.
    Baillie Gifford is proud to call Edinburgh home. And we take every opportunity to show it off to the world in its best light. In this case we did so by supporting the Regent Bridge installation.
    Watch
    Read more
    Insights
    Cities of Tomorrow.
    Joe Faraday shares his enthusiasm for the importance of cities as growth drivers, explaining how access to world-leading academics and their research has shaped his thinking.
    Read more
    Read more
    Insights
    Genomics: Reasons for Optimism.
    Julia Angeles, an investment manager in the EAFE Alpha team, considers how scientific developments have led to changes in the diagnosis and treatment of diseases, and why the current rate of progress is set to accelerate in the coming years. Angeles also explains why she opted to undergo genomic testing.
    Read more